Proof that this was a "cleaner" Tour

WSJ NEWS ALERT: Amgen Plans to Cut Work Force Amid Slump in Aranesp Drug

from The Wall Street Journa

Aug. 15, 2007

Amgen said it will cut staff by up to 14%, slash capital expenses by $1.9
billion, and close some production facilities in an effort to offset
slumping sales of its top-selling anemia drug Aranesp. The restructuring --
unprecedented in the biotech giant's 27-year history -- will trigger $600
million to $700 million in pre-tax charges. Amgen also cut its 2007 earnings
estimate, previously $4.28 a share, down to a range of $4.13 to $4.23,
compared with $3.90 a year earlier.

FOR MORE INFORMATION, see:
http://wsj.com/article/0,,SB11872052...?mod=djemalert

Mark VandenBerghe wrote:
WSJ NEWS ALERT: Amgen Plans to Cut Work Force Amid Slump in Aranesp Drug


They should advertise in:
http://www.geezerjock.com/public/335.cfm

"Dan Connelly" wrote in message
et...
Mark VandenBerghe wrote:
WSJ NEWS ALERT: Amgen Plans to Cut Work Force Amid Slump in Aranesp Drug


They should advertise in:
http://www.geezerjock.com/public/335.cfm

Dsn, you're beginning to have some serious problems. I suggest you aren't
winning because you're getting older.